Specialty Pharmacy

National Institutes of Health awards $9.4 million to improve HIV health care.

Top articles of the week on Specialty Pharmacy Times.

Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses how specialty pharmacies can optimize the prior authorization process.

Pharmacy benefit manager alliance with retail pharmacy giant Walgreens is the first of its kind.

Researchers reveal how anti-HIV inhibitors bind to the wrong target.

Praluent lowers LDL cholesterol in patients with heterozygous familial hypercholesterolemia (HeFH).

CRISPR-Cas9 stabilizes the guide RNA in live cells.

Combinations with hypoxia-activated prodrugs may eliminate non-small cell lung cancer tumors.

Top news of the day from across the healthcare landscape.

Paul LeVine, vice president of Analytic Services at TrialCard, discusses how specialty pharmacies can best utilize data to improve patient outcomes.

Erelzi, an etanercept biosimilar, was approved for rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and polyarticular juvenile idiopathic arthritis.

Pharmacokinetics of tecarfarin were not compromised by renal function like it was with warfarin.

The toxicity of cancer drugs increasingly causing cardiovascular complications in patients.

Top news of the day from across the health care landscape.

Researchers seek to reduce the significant HIV risk among homeless people.

Research advances work towards targeted therapies for type 2 diabetes.

FDA advises nucleic acid tests to screen for hepatitis B virus.

Self-reported psychological well-being superior in patients with leukemia after a bone marrow transplant compared with peripheral blood transplants.

Some breast cancer tumors are not sensitive to Herceptin.

How specialty pharmacies can improve the treatment success of women receiving in-vitro fertilization.

Researchers examine whether cognitive impairment caused by chemotherapy drugs in breast cancer patients is a long-term issue.

Genes related to eye color may cause cancer of the eye.

Top news of the day from across the healthcare landscape.

Cancer genomics reveal genetic mutations that aid tumor growth in prostate cancer.

Treating cellular survival mechanism may prove to be a promising treatment approach for cancer.

Prescribed diabetes therapies may be leading to reduced kidney function.

New method able to reduce toxic side effects by avoiding use of chemotherapy.

Optimizing workflow can enhance the specialty pharmacy patient experience.